Personal CFO Solutions’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497K | Buy |
4,485
+386
| +9% | +$42.8K | 0.09% | 225 |
|
|
2025
Q1 | $459K | Buy |
4,099
+1,857
| +83% | +$208K | 0.09% | 221 |
|
|
2024
Q4 | $207K | Buy |
+2,242
| New | +$207K | 0.04% | 436 |
|
|
2024
Q2 | – | Sell |
-3,114
| Closed | -$228K | – | 564 |
|
|
2024
Q1 | $228K | Buy |
3,114
+168
| +6% | +$12.3K | 0.04% | 487 |
|
|
2023
Q4 | $239K | Sell |
2,946
-4,976
| -63% | -$403K | 0.04% | 438 |
|
|
2023
Q3 | $594K | Sell |
7,922
-749
| -9% | -$56.1K | 0.12% | 165 |
|
|
2023
Q2 | $668K | Sell |
8,671
-2,079
| -19% | -$160K | 0.14% | 151 |
|
|
2023
Q1 | $892K | Sell |
10,750
-350
| -3% | -$29K | 0.18% | 102 |
|
|
2022
Q4 | $958K | Buy |
11,100
+4,662
| +72% | +$402K | 0.2% | 95 |
|
|
2022
Q3 | $397K | Buy |
6,438
+238
| +4% | +$14.7K | 0.1% | 194 |
|
|
2022
Q2 | $383K | Sell |
6,200
-375
| -6% | -$23.2K | 0.09% | 206 |
|
|
2022
Q1 | $391K | Buy |
+6,575
| New | +$391K | 0.08% | 246 |
|
|
2021
Q4 | – | Sell |
-10,624
| Closed | -$742K | – | 487 |
|
|
2021
Q3 | $742K | Buy |
10,624
+773
| +8% | +$54K | 0.15% | 136 |
|
|
2021
Q2 | $678K | Buy |
9,851
+1,095
| +13% | +$75.4K | 0.14% | 142 |
|
|
2021
Q1 | $566K | Buy |
8,756
+4
| +0% | +$259 | 0.12% | 152 |
|
|
2020
Q4 | $510K | Sell |
8,752
-4,150
| -32% | -$242K | 0.13% | 157 |
|
|
2020
Q3 | $1K | Sell |
12,902
-164
| -1% | -$13 | 0.33% | 77 |
|
|
2020
Q2 | $1.01M | Sell |
13,066
-303
| -2% | -$23.3K | 0.3% | 77 |
|
|
2020
Q1 | $999K | Buy |
13,369
+1,506
| +13% | +$113K | 0.36% | 62 |
|
|
2019
Q4 | $771K | Sell |
11,863
-3,488
| -23% | -$227K | 0.22% | 98 |
|
|
2019
Q3 | $1.08M | Buy |
+15,351
| New | +$1.08M | 0.43% | 56 |
|